Convalescent Plasma News and Research

RSS

Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections

Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against respiratory viruses like influenza A and SARS-CoV-2 by inducing interferon-stimulated gene (ISG) expression, independent of microbiota and interferon activation.

24 Apr 2024

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

Study published in Nature Immunology reveals that repeated mRNA COVID-19 vaccinations enhance immune response, especially in previously infected individuals, leading to a diversified and increased number of immune cell clones and a stronger ability to combat various virus strains.

7 Dec 2023

Study shows benefit of convalescent plasma in Covid-19 patients requiring artificial ventilation

In a study published in The New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality (10%).

25 Oct 2023

Early treatment with convalescent plasma may reduce risk of long COVID

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions -; commonly known as long COVID -; if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.

20 Sep 2023

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Researchers have isolated a new SARS-CoV-2 Omicron subvariant, BA.2.86, revealing its ability to escape neutralizing antibodies five-fold greater than its ancestor strain. Despite its enhanced immune evasion capabilities, BA.2.86 has not shown a significant difference in spread compared to other current variants.

13 Sep 2023

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Researchers identify a new SARS-CoV-2 variant, BA.2.86, with enhanced ability to evade immunity but lower infectivity compared to current variants. The study highlights the need for global monitoring due to its potential to become a predominant strain if it gains infectivity through mutations.

6 Sep 2023

Convalescent Plasma News and Research

Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

Study shows benefit of convalescent plasma in Covid-19 patients requiring artificial ventilation

Early treatment with convalescent plasma may reduce risk of long COVID

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?

Inflammatory profiles in vaccinated vs. unvaccinated individuals following SARS-CoV-2 infection

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Evolutionary convergence of the SARS-CoV-2 A-lineage spike sequences

Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses

New analysis shows how convalescent plasma can be used as effective, low-cost COVID-19 treatment

Antibodies against SARS-CoV-2 are higher in infants than in mothers

What are the predictors of in-hospital mortality in cancer patients with COVID-19?

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

On four flights out of China in December, 22% of passengers were SARS-CoV-2 positive

COVID-19 convalescent plasma transfusions significantly reduced mortality rates among hospitalized SARS-CoV-2 patients

What are the long-term outcomes of critical COVID-19 patients?

COVID-19 epidemiology can be estimated using blood donation samples

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News